Stock comparison

LLYvsMSFT

Eli Lilly and Co vs Microsoft Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$927.03

-6.70%

Pharmaceuticals$884.0BNYSE

MSFT

Microsoft Corp

$422.79

-13.20%

Technology$2.77TNASDAQ

60-day price, rebased to 100

LLY -12.77% · MSFT -0.14%

Round-by-round

LLY 1·MSFT 5

EdgeMSFT

Valuation upside

-92.70% vs -79.40% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 15.74 vs 10.53

EdgeMSFT

Fundamental quality

Piotroski 6.00 vs 8.00 (of 9)

EdgeMSFT

Growth + margins

Rule-of-40 -9.10 vs 44.40

EdgeMSFT

60-day momentum

-12.77% vs -0.14% price return

EdgeMSFT

Market-cap liquidity

$884.0B vs $2.77T

Verdict

Across 6 categories, MSFT takes the edge with 5 wins to 1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on LLY or MSFT

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.